Skip to main content

Prion Disease clinical trials at UCLA

1 research study open to eligible people

Showing trials for
  • Pharmacodynamics of ION717.

    open to eligible people ages 18 years and up

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of intrathecal (IT) delivery of ION717.

    Los Angeles, California and other locations

Last updated: